GlassScriptPhysician profile
Todd Griffin
NPI 1942898085
$1,233.01
in general payments reported to CMS, 2019-2025
15 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $766 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $311.13 | 2024-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $200.02 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $178.52 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Corcept Therapeutics | $163.29 | 2024-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $125.10 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.72 | 2024 | Jardiance, Synjardy, Tradjenta |
| Ascendis Pharma Endocrinology INC | $29.36 | 2025 | Yorvipath |
| Kyowa Kirin, INC. | $26.22 | 2025 | |
| Amgen INC. | $26.07 | 2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $24.62 | 2024 | |
| Xeris Pharmaceuticals, INC. | $24.58 | 2025 | Gvoke Hypopen |
| Beta Bionics, INC. | $24.09 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amneal Pharmaceuticals LLC | $21.34 | 2024 | Unithroid |
| Abbvie INC. | $20.29 | 2024 | |
| Cequr Corporation | $16.66 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.